2 days agoMost coronavirus patients will develop symptoms, study analysis arguesThe authors said as many as four in five coronavirus patients may develop symptoms.
3 days agoConjoined Michigan twins separated in 11-hour surgeryThe girls had lived their first 13 months attached from the chest to the belly button.
4 days agoCoffee may help colon cancer patients’ longevity, study findsIn addition to possibly helping to protect the liver, coffee could also aide in colon cancer patients’ longevity, according to a new study.
6 days agoDrug-therapy combo cuts breast cancer recurrence risk by 25%, Eli Lilly announcesEli Lilly and Company on Sunday announced positive results on the fight against breast cancer.
September 18Coronavirus therapeutics 'more complicated' than vaccine, expert saysEditors of a highly respected medical journal conducted an interview on Wednesday exploring the U.S. government’s Operation Warp Speed plan and its approach to COVID-19 countermeasures, including therapies.
September 18Texas coronavirus patient, 70, undergoes double lung transplantTexas surgeons performed a double lung transplant after the novel coronavirus damaged the lungs of a 70-year-old man.
September 16Ronald McDonald House raises awareness for childhood cancer with 'September Step Up' challengeRuth Browne, president and CEO of the Ronald McDonald House in New York City, said Wednesday that there's good news to report in the battle against cancer and highlighted the organization's "September Step Up" challenge, which is geared toward raising funds for patient care.
2:02September 15University of Pittsburgh researchers isolates biological molecule that blocks COVID-19Researchers optimistic drug could be used to treat COVID-19 in patients; Garrett Tenney reports.
2:13September 8San Francisco scientists say they have developed synthetic 'nanobody' that blocks COVID-19Scientist work to stop coronavirus in the body before it has a chance to spread; Claudia Cowan reports.
September 4Prominent US doctors break down which coronavirus tests will curb transmission ratesTop infectious disease doctors from Harvard and Johns Hopkins break down the differences between the two tests to determine which diagnostic tools might be better at curbing transmission rates.
